Cisen Pharmaceutical Co (SHSE:603367) Other Current Payables: ¥323 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603367 Cisen Pharmaceutical Co Ltd SHSE:603367
66 GF Score
Price ¥15.33
GF Value ¥11.33
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Cisen Pharmaceutical Co Other Current Payables?

Cisen Pharmaceutical Co SHSE:603367 +4.78% 66 Other Current Payables is ¥323 Mil as of Mar. 2026. GuruFocus rates SHSE:603367 with a GF Score™ of 66/100 and a GF Value™ of ¥11.33 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Cisen Pharmaceutical Co's Other Current Payables for the quarter that ended in Mar. 2026 was ¥323 Mil.

Cisen Pharmaceutical Co's quarterly Other Current Payables declined from Sep. 2025 (¥393 Mil) to Dec. 2025 (¥283 Mil) but then increased from Dec. 2025 (¥283 Mil) to Mar. 2026 (¥323 Mil).

Cisen Pharmaceutical Co's annual Other Current Payables increased from Dec. 2023 (¥368 Mil) to Dec. 2024 (¥387 Mil) but then declined from Dec. 2024 (¥387 Mil) to Dec. 2025 (¥283 Mil).

Cisen Pharmaceutical Co Other Current Payables Related Terms

Cisen Pharmaceutical Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Cisen Pharmaceutical Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cisen Pharmaceutical Co Other Current Payables Chart

Cisen Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 256.67 280.98 367.97 386.54 283.30

Cisen Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 409.01 372.76 393.42 283.30 322.66
SHSE:603367
66GF Score
Cisen Pharmaceutical Co Ltd SHSE:603367
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cisen Pharmaceutical Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ¥323 Mil mean?
Cisen Pharmaceutical Co (SHSE:603367) has a Other Current Payables of ¥323 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cisen Pharmaceutical Co and its competitors.
Is Cisen Pharmaceutical Co's Other Current Payables too high?
Cisen Pharmaceutical Co's current Other Current Payables is ¥323 Mil. Overall, Cisen Pharmaceutical Co has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cisen Pharmaceutical Co's Other Current Payables compare to ZTS?
Cisen Pharmaceutical Co's Other Current Payables of ¥323 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cisen Pharmaceutical Co and its competitors. Cisen Pharmaceutical Co's current Other Current Payables is ¥323 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cisen Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Cisen Pharmaceutical Co (SHSE:603367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥11.33, compared to a current price of ¥15.33 — trading 35.3% above its estimated fair value. The current Other Current Payables is ¥323 Mil. Cisen Pharmaceutical Co's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Cisen Pharmaceutical Co (SHSE:603367), the current Other Current Payables is ¥323 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cisen Pharmaceutical Co (SHSE:603367) Overvalued in 2026?

Based on GuruFocus' analysis, Cisen Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥15.33 is trading 35.3% above its estimated GF Value™ of ¥11.33. GuruFocus considers Cisen Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603367:

  • Other Current Payables: ¥323 Mil
  • GF Value™: ¥11.33 vs. price of ¥15.33 (35.3% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the SHSE:603367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cisen Pharmaceutical Co Business Description

Address Tongji Sci-tech Industrial Park, High-tech Industrial Development Zone, Shandong, Jining, CHN, 272073
Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.
66GF Score

Get the complete analysis for SHSE:603367

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.33
Price
¥11.33
GF Value